Royal Bank Of Canada Boosts Uniphar (LON:UPR) Price Target to GBX 480

Uniphar (LON:UPR) had its target price hoisted by research analysts at Royal Bank Of Canada from GBX 470 to GBX 480 in a research report issued to clients and investors on Tuesday,Digital Look reports. The firm currently has an “outperform” rating on the stock. Royal Bank Of Canada’s target price indicates a potential upside of 39.53% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Shore Capital reissued a “buy” rating on shares of Uniphar in a research note on Thursday, May 29th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a GBX 375 price objective on shares of Uniphar in a research note on Wednesday, July 30th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, Uniphar presently has a consensus rating of “Moderate Buy” and an average price target of GBX 427.50.

Uniphar Stock Down 0.9%

Shares of LON UPR opened at GBX 344 on Tuesday. The stock has a market capitalization of £892.93 million, a price-to-earnings ratio of 1,404.08 and a beta of 0.75. Uniphar has a 52 week low of GBX 163 and a 52 week high of GBX 368. The firm has a 50-day moving average price of GBX 334.18 and a 200 day moving average price of GBX 285.96. The company has a quick ratio of 0.60, a current ratio of 0.90 and a debt-to-equity ratio of 119.48.

About Uniphar

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.